Use of azacitidine and its safety and efficacy in daily clinical practice in The Netherlands: the OCEAN study

Leuk Lymphoma. 2020 Nov;61(11):2752-2755. doi: 10.1080/10428194.2020.1775217. Epub 2020 Jun 12.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antimetabolites, Antineoplastic / adverse effects
  • Azacitidine* / adverse effects
  • Humans
  • Myelodysplastic Syndromes* / drug therapy
  • Netherlands
  • Treatment Outcome

Substances

  • Antimetabolites, Antineoplastic
  • Azacitidine